Xspray Pharma AB (publ) (STO:XSPRAY)

Status Update

← View all transcripts

Sep 12, 2023

Operator

[Foreign language]

Per Andersson

CEO, Xspray Pharma

[Foreign language]

[Foreign language]

[Foreign language]

[Foreign language]

[Foreign language]

[Foreign language]

Operator

[Foreign language]

[Foreign language]

Dan Akschuti

Equity Partner and Biotech Analyst, Pareto Securities

[Foreign language]

Per Andersson

CEO, Xspray Pharma

[Foreign language]

Dan Akschuti

Equity Partner and Biotech Analyst, Pareto Securities

[Foreign language]

Per Andersson

CEO, Xspray Pharma

[Foreign language]

[Foreign language]

Dan Akschuti

Equity Partner and Biotech Analyst, Pareto Securities

[Foreign language]

Per Andersson

CEO, Xspray Pharma

[Foreign language]

[Foreign language]

[Foreign language]

Operator

[Foreign language]

Speaker 4

[Foreign language]

Per Andersson

CEO, Xspray Pharma

[Foreign language]

Speaker 4

[Foreign language]

Per Andersson

CEO, Xspray Pharma

[Foreign language]

[Foreign language]

[Foreign language]

Speaker 4

[Foreign language]

Per Andersson

CEO, Xspray Pharma

[Foreign language]

[Foreign language]

Speaker 4

[Foreign language]

Per Andersson

CEO, Xspray Pharma

[Foreign language]

Speaker 4

[Foreign language]

Operator

[Foreign language]

Per Andersson

CEO, Xspray Pharma

[Foreign language]

Speaker 4

[Foreign language]

Per Andersson

CEO, Xspray Pharma

[Foreign language]

Speaker 4

[Foreign language]

Per Andersson

CEO, Xspray Pharma

[Foreign language]

Speaker 4

[Foreign language]

Per Andersson

CEO, Xspray Pharma

[Foreign language]

Operator

[Foreign language]

Per Andersson

CEO, Xspray Pharma

[Foreign language]

[Foreign language] .

[Foreign language]

Operator

[Foreign language]

Per Andersson

CEO, Xspray Pharma

[Foreign language]

Powered by

• Press Release